Nonprofit gene therapy for Wiskott-Aldrich syndrome reaches the US
The arrival expands treatment options for rare immune disorders, though access challenges persist.
Read at BioXconomy โThe arrival expands treatment options for rare immune disorders, though access challenges persist.
Read at BioXconomy โ